探索最优化的肾上腺静脉取血路径及导管选择

Optimal pathway and catheter selection for adrenal venous sampling

  • 摘要:
    目的 探讨单条肘前静脉路径、双条肘前静脉路径、肘前静脉联合股静脉路径进行肾上腺静脉取血(AVS)的可行性与安全性,以及AVS对腹腔镜手术预后的指导价值。
    方法 回顾性分析2021年1月至2025年6月在福建医科大学附属第一医院进行AVS的220例原发性醛固酮增多症(PA)患者。根据AVS路径,分为单条肘前静脉路径(单肘组,n=78)、双条肘前静脉路径(肘双管组,n=70)、单条肘前静脉联合单条股静脉路径(股肘组,n=72)。比较各组基线资料、取血成功率、曝光时间、并发症、导管选择及腹腔镜手术后临床缓解与生化缓解情况。
    结果 三组基线资料差异无统计学意义。与单肘组相比,肘双管组取血成功率:90.00%比71.80%,x2=7.761,P=0.015;曝光时间:(11.90±3.04)比(16.03±3.55)min,t=7.547,P<0.001和股肘组取血成功率:88.90%比71.80%,x2=6.838,P=0.027;曝光时间:(8.45±2.65)比(16.03±3.55)min,t=14.693,P<0.001在取血成功率、曝光时间上优于单肘组。与肘双管组相比,股肘组取血成功率差异无统计学意义(P>0.05),曝光时间减少(P<0.001)。与股肘组相比,肘双管组穿刺部位并发症发生率有减少趋势,但差异无统计学意义(5.71%比12.50%,x2=1.965,P>0.05)。右侧AVS的导管选择上,股肘组提供了更多样化的导管选择。左侧AVS的导管选择上,单肘组和肘双管组多使用TIG导管,股肘组多使用MP导管。三组PA患者的临床评价和生化评价差异无统计学意义。
    结论 经双条肘前静脉和单条肘前静脉联合单条股静脉路径均可以高效完成AVS。肘前静脉联合股静脉路径曝光时间更短。

     

    Abstract:
    Objective To assess the feasibility and safety of adrenal venous sampling (AVS) via single antecubital venous access, bilateral antecubital venous access, and combined antecubital-femoral venous access, as well as the prognostic value of AVS for guiding laparoscopic surgery.
    Methods This retrospective study included 220 patients with primary aldosteronism(PA)who underwent AVS at the First Affiliated Hospital of Fujian Medical University between January 2021 and June 2025. Based on the AVS approach, patients were categorized into three groups: single antecubital group (n=78), bilateral antecubital group (n=70), and combined femoral-antecubital group (n=72). Inter-group comparisons were performed for baseline characteristics, AVS success rate, radiation exposure time, procedure-related complications, catheter selection, and postoperative clinical and biochemical remission rates following laparoscopic adrenalectomy.
    Results No significant differences were observed in baseline characteristics among the three groups. Compared to the single antecubital group, both the bilateral antecubital group and the combined femoral-antecubital group demonstrated significantly higher AVS success rates (bilateral antecubital group vs single antecubital group: 90.00% vs. 71.80%, x2=7.761, P = 0.015; combined femoral-antecubital group vs. single antecubital group: 88.90% vs. 71.80%, x2=6.838, P = 0.027) and significantly shorter radiation exposure times (bilateral antecubital group vs. single antecubital group: 11.90 ± 3.04 vs. 16.03 ± 3.55 min, t=7.547, P < 0.001, combined femoral-antecubital group vs. single antecubital group: 8.45 ± 2.65 vs. 16.03 ± 3.55 min, t=14.693, P < 0.001).Compared to the bilateral antecubital group, the combined femoral-antecubital group demonstrated comparable AVS success rates (P > 0.05) but significantly shorter radiation exposure times (P<0.001). Procedure-related complications demonstrated a lower incidence of puncture site events in the bilateral antecubital group versus the combined femoral-antecubital group (5.71% vs. 12.50%, x2=1.965, P>0.05), though this difference was not statistically significant. Regarding catheter selection for right AVS, the combined femoral-antecubital approach demonstrated greater catheter diversity. For left AVS, both single and bilateral antecubital approaches predominantly utilized TIG catheters versus preferential MP catheter use in the combined femoral-antecubital group.The choice among the three AVS pathways showed no statistically significant difference in clinical and biochemical outcomes for PA patients following laparoscopic adrenalectomy.
    Conclusion Both bilateral antecubital approach and combined antecubital-femoral approach enable efficient AVS completion. Moreover, the combined antecubital-femoral approach demonstrates reduced radiation exposure time.

     

/

返回文章
返回